Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: A protocol for a systematic review and network meta-analysis of primary prevention trials

Systematic Reviews

Volumn 4, Issue 1, 2015, Pages

  Schwingshackl, Lukas ^a,b   Hoffmann, Georg ^a   Buijsse, Brian ^b   Mittag, Tamara ^b   Stelmach Mardas, Marta ^b,c   Boeing, Heiner ^b   Gottschald, Marion ^b   Dietrich, Stefan ^b   Arregui, Maria ^b   Dias, Sofia ^d  

^a UNIVERSITY OF VIENNA   (Austria)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cancer; Cardiovascular; Dietary supplements; Incidence; Mortality; Network meta analysis; Systematic review

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID; ASCORBIC ACID; BETA CAROTENE; CALCIUM; COPPER; IODINE; IRON; MAGNESIUM; MONOUNSATURATED FATTY ACID; MULTIVITAMIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POTASSIUM; PREBIOTIC AGENT; PROBIOTIC AGENT; PROTEIN; RETINOL; SELENIUM; SYNBIOTIC AGENT; VITAMIN B GROUP; VITAMIN D; ZINC; TRACE ELEMENT; UNSATURATED FATTY ACID;

ARTICLE; CARDIOVASCULAR DISEASE; COMPARATIVE EFFECTIVENESS; DATA EXTRACTION; DIET SUPPLEMENTATION; DIETARY FIBER; HUMAN; INCIDENCE; META ANALYSIS; MORTALITY; NEOPLASM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SAFETY; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CLINICAL PROTOCOL; DIETARY SUPPLEMENT; METHODOLOGY; NEOPLASMS;

AMINO ACIDS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CLINICAL PROTOCOLS; DIETARY FIBER; DIETARY SUPPLEMENTS; FATTY ACIDS, UNSATURATED; HUMANS; MICRONUTRIENTS; NEOPLASMS; RESEARCH DESIGN;

EID: 84939183297     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/s13643-015-0029-z     Document Type: Article

References (37)

1. Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003-2006. J Nutr. 2011;141:261-6.
2. Brzozowska A, Enzi G, Amorin CJ. Medicine use and supplementation practice among participants of SENECA Study. J Nutr Health Aging. 2002;6:34-8.
3. Skeie G, Braaten T, Hjartaker A, Lentjes M, Amiano P, Jakszyn P, et al. Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr. 2009;63 Suppl 4:S226-38.
4. Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008;26:665-73.
5. Rock CL. Multivitamin-multimineral supplements: who uses them? Am J Clin Nutr. 2007;85:277S-9.
6. Macpherson H, Pipingas A, Pase MP. Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2013;97:437-44.
7. Biesalski HK, Grune T, Tinz J, Zollner I, Blumberg JB. Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials. Nutrients. 2010;2:929-49.
8. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842-57.
9. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Krstic G, Wetterslev J, et al. Vitamin D supplementation for prevention of cancer in adults. Cochrane Database Syst Rev. 2014;6, CD007469.
10. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014;1, CD007470.
11. Huang T, Chen Y, Yang B, Yang J, Wahlqvist ML, Li D. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr. 2012;31:448-54.
12. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med. 2010;170:1622-31.
13. Bristow SM, Bolland MJ, MacLennan GS, Avenell A, Grey A, Gamble GD, et al. Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials. Br J Nutr. 2013;110:1384-93.
14. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012;308:1024-33.
15. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160:398-406.
16. Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B. Omega 3 fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2012;5:808-18.
17. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol. 2009;32:365-72.
18. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
19. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati AD, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.
20. European Parliament and Council (2002). Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the member states relating to food supplements. OffJ Eur Commun L183, 12.07.2002, pp 51-57 (http://old.eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32002L0046:EN:NOTaccessed 07.01.2015).
21. de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008;111:1-66.
22. Higgins JP, Green S. Cochrane handbook of systematic reviews, Version 5.1.0 updated. 2011.
23. Liberati A, Altman DG, TetzlaffJ, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
24. Moher D, Liberati A, TetzlaffJ, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
25. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
26. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383-94.
27. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
29. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
30. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
31. Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33:607-17.
32. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. J Royal Statistical Soc (B). 2002;64:583-616.
33. Dias S, Welton NJ, Sutton AJ, Ades AE: NICE DSU Technical Support Document 2: A generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. (available at: http://www.nicedsu.org.uk, accessed on 05.09.2013). 2011.
34. Lunn DJ, Thomas A, Best N. D S: WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000;10:325-37.
35. Brooks SP, Aad G. Alternative methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998;7:434-55.
36. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29:932-44.
37. Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making. 2013;33:641-56.